Last update :
16/06/2024
References   References 2212  
Type : Manufacturer

Research teams :
Authors :
Title : Reteplase (Rapilysin®) - Summary of Product Characteristics
Reference : Actavis UK Ltd 2015

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAcetylsalicylic acid lysinate Analgesic
Incompatible + InjectionReteplase
InjectionHeparin sodium Anticoagulant
Incompatible + InjectionReteplase
InjectionReteplase Thrombolytic
Stability in solutions Glass Water for Injection 1 UI/ml 2-30°C Not specified
8 Hour
Incompatible + InjectionAcetylsalicylic acid lysinate
Incompatible + InjectionHeparin sodium

  Mentions Légales